997 related articles for article (PubMed ID: 7510619)
1. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
Wagstaff AJ; Faulds D; Goa KL
Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
[TBL] [Abstract][Full Text] [Related]
2. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
Ormrod D; Scott LJ; Perry CM
Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
[TBL] [Abstract][Full Text] [Related]
3. Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
O'Brien JJ; Campoli-Richards DM
Drugs; 1989 Mar; 37(3):233-309. PubMed ID: 2653790
[TBL] [Abstract][Full Text] [Related]
4. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.
Richards DM; Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Nov; 26(5):378-438. PubMed ID: 6315332
[TBL] [Abstract][Full Text] [Related]
5. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Faulds D
Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
[TBL] [Abstract][Full Text] [Related]
6. Genital herpes. A guide to pharmacological therapy.
de Ruiter A; Thin RN
Drugs; 1994 Feb; 47(2):297-304. PubMed ID: 7512902
[TBL] [Abstract][Full Text] [Related]
7. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
Wutzler P
Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
[TBL] [Abstract][Full Text] [Related]
8. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.
Snoeck R; Andrei G; De Clercq E
Drugs; 1999 Feb; 57(2):187-206. PubMed ID: 10188760
[TBL] [Abstract][Full Text] [Related]
9. Viral prophylaxis in organ transplant patients.
Slifkin M; Doron S; Snydman DR
Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
[TBL] [Abstract][Full Text] [Related]
10. Valaciclovir: a review of its use in the management of herpes zoster.
Ormrod D; Goa K
Drugs; 2000 Jun; 59(6):1317-40. PubMed ID: 10882165
[TBL] [Abstract][Full Text] [Related]
11. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
[TBL] [Abstract][Full Text] [Related]
12. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
13. Viral skin infections in the elderly: diagnosis and management.
Bansal R; Tutrone WD; Weinberg JM
Drugs Aging; 2002; 19(7):503-14. PubMed ID: 12182687
[TBL] [Abstract][Full Text] [Related]
14. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Wagstaff AJ
Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients.
Fillet AM
Drugs Aging; 2002; 19(5):343-54. PubMed ID: 12093321
[TBL] [Abstract][Full Text] [Related]
16. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Tan HH; Goh CL
Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
[TBL] [Abstract][Full Text] [Related]
17. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir.
Steer CB; Szer J; Sasadeusz J; Matthews JP; Beresford JA; Grigg A
Bone Marrow Transplant; 2000 Mar; 25(6):657-64. PubMed ID: 10734301
[TBL] [Abstract][Full Text] [Related]
18. Antivirals for the treatment of herpesvirus infections.
De Clercq E
J Antimicrob Chemother; 1993 Jul; 32 Suppl A():121-32. PubMed ID: 8407694
[TBL] [Abstract][Full Text] [Related]
19. New antiherpesvirus agents. Their targets and therapeutic potential.
Alrabiah FA; Sacks SL
Drugs; 1996 Jul; 52(1):17-32. PubMed ID: 8799682
[TBL] [Abstract][Full Text] [Related]
20. Valaciclovir: development, clinical utility and potential.
Patel R
Expert Opin Investig Drugs; 1997 Feb; 6(2):173-89. PubMed ID: 15989601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
